X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences (3) 3
[ sdv ] life sciences [q-bio] (2) 2
[chim]chemical sciences (2) 2
[sdv]life sciences [q-bio] (2) 2
auristatin (2) 2
biodistribution (2) 2
chemical sciences (2) 2
human necessities (2) 2
humans (2) 2
hygiene (2) 2
index medicus (2) 2
internalization (2) 2
medical or veterinary science (2) 2
monoclonal antibody-drug conjugate (2) 2
oncology (2) 2
preparations for medical, dental, or toilet purposes (2) 2
tn antigen (2) 2
toxicity (2) 2
adult (1) 1
adults (1) 1
aged (1) 1
aged, 80 and over (1) 1
aminobenzoates - chemistry (1) 1
antineoplastic agents - chemistry (1) 1
atrophy (1) 1
b-subunit (1) 1
cancer (1) 1
cancer-therapy (1) 1
carbamate (1) 1
cells (1) 1
chemistry, medicinal (1) 1
chemotherapy (1) 1
combined modality therapy (1) 1
conjugate (1) 1
disulfide (1) 1
drug carriers - chemistry (1) 1
drugs (1) 1
epitopes (1) 1
experimental design (1) 1
expression (1) 1
extremity (1) 1
feasibility studies (1) 1
female (1) 1
hafnium (1) 1
hafnium - administration & dosage (1) 1
hafnium - chemistry (1) 1
hafnium oxide (1) 1
hafnium oxide nanoparticles (1) 1
high-grade (1) 1
ht29 cells (1) 1
hydrophobic and hydrophilic interactions (1) 1
immunology (1) 1
in-vivo (1) 1
induced pathological necrosis (1) 1
injection (1) 1
linkers (1) 1
magnetic resonance imaging (1) 1
male (1) 1
management (1) 1
mechanisms (1) 1
middle aged (1) 1
mmaf (1) 1
models, molecular (1) 1
monoclonal-antibody (1) 1
nanoparticles (1) 1
nanoparticles - administration & dosage (1) 1
nanoparticles - chemistry (1) 1
neoadjuvant radiotherapy (1) 1
neoplasm recurrence, local - drug therapy (1) 1
neoplasm recurrence, local - pathology (1) 1
neoplasm recurrence, local - radiotherapy (1) 1
neoplasm, residual - drug therapy (1) 1
neoplasm, residual - pathology (1) 1
neoplasm, residual - radiotherapy (1) 1
oligopeptides - chemistry (1) 1
original research (1) 1
oxides - administration & dosage (1) 1
oxides - chemistry (1) 1
pain (1) 1
patients (1) 1
postoperative radiotherapy (1) 1
preoperative care (1) 1
preoperative radiotherapy (1) 1
prodrugs (1) 1
protein conformation (1) 1
radiation (1) 1
radiation therapy (1) 1
radiotherapy dosage (1) 1
radiotherapy, adjuvant - adverse effects (1) 1
randomized-trial (1) 1
retrograde delivery (1) 1
safety engineering (1) 1
sarcoma (1) 1
sarcoma - drug therapy (1) 1
sarcoma - pathology (1) 1
sarcoma - radiotherapy (1) 1
shiga toxin (1) 1
shiga toxin - chemistry (1) 1
shrinkage (1) 1
soft tissue sarcoma (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 908 - 917
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 05/2015, Volume 95, pp. 483 - 491
Journal Article
OncoImmunology, ISSN 2162-4011, 07/2016, Volume 5, Issue 7, p. e1171434
Antibody-drug conjugates (ADC), combining the specificity of tumor recognition by monoclonal antibodies (mAb) and the powerful cytotoxicity of anticancer... 
MMAF | internalization | Tn antigen | Biodistribution | monoclonal antibody-drug conjugate | CELLS | AURISTATIN | SPECIFICITY | MONOCLONAL-ANTIBODY | MECHANISMS | IMMUNOLOGY | CANCER-THERAPY | ONCOLOGY | IN-VIVO | EXPRESSION | EPITOPES | Life Sciences | Chemical Sciences
Journal Article
OncoImmunology, ISSN 2162-4011, 04/2016, Volume 5, Issue 7, p. e1171434
Antibody-drug conjugates (ADC), combining the specificity of tumor recognition by monoclonal antibodies (mAb) and the powerful cytotoxicity of anticancer... 
Life Sciences
Journal Article
06/2014
Multivalent conjugates comprising the following formula: (STxB-linker A-S)x-GNS-(S-linker B-T)y wherein STxB is the B-subunit of Shiga toxin; linker A is a... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.